Related references
Note: Only part of the references are listed.CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity
Won-Tak Choi et al.
JOURNAL OF VIROLOGY (2012)
New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection
Javier Garcia-Perez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)
Javier Garcia-Perez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification and Characterization of INCB9471, an Allosteric Noncompetitive Small-Molecule Antagonist of C-C Chemokine Receptor 5 with Potent Inhibitory Activity against Monocyte Migration and HIV-1 Infection
Niu Shin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors
Reem Berro et al.
JOURNAL OF VIROLOGY (2011)
The chemokine receptor CCR5 in the central nervous system
Silvia Sorce et al.
PROGRESS IN NEUROBIOLOGY (2011)
CC Chemokine Receptor 5 (CCR5) Desensitization CYCLING RECEPTORS ACCUMULATE IN THE TRANS-GOLGI NETWORK
Jean-Michel Escola et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
David A. Zidar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The apparent cooperativity of some GPCRs does not necessarily imply dimerization
Marc Chabre et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5
T. Nakajima et al.
CYTOGENETIC AND GENOME RESEARCH (2008)
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide
Hubert Gaertner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Highly potent HIV inhibition:: engineering a key anti-HIV structure from PSC-RANTES into MIP-1β/CCL4
Hubert Gaertner et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Identification of a postendocytic sorting sequence in CCR5
Maurine Delhaye et al.
MOLECULAR PHARMACOLOGY (2007)
Conformational complexity of G-protein-coupled receptors
Brian K. Kobilka et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Diverse signalling by different chemokines through the chemokine receptor CCR5
Anja Mueller et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes
Celine Gales et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers
JY Springael et al.
MOLECULAR PHARMACOLOGY (2006)
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis
B Lagane et al.
MOLECULAR PHARMACOLOGY (2005)
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility
E Gonzalez et al.
SCIENCE (2005)
Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: A complex network of interactions influencing viral replication and AIDS pathogenesis
L Fantuzzi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type I isolates
A Amara et al.
JOURNAL OF VIROLOGY (2003)
Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis
A Kinter et al.
IMMUNOLOGICAL REVIEWS (2000)
Evaluation of the putative role of C-C chemokines as protective factors of HIV-1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives
J Barretina et al.
TRANSFUSION (2000)
Share Paper
